Bioventus (BVS) Return on Capital Employed (2021 - 2026)
Bioventus' (BVS) quarterly Return on Capital Employed came in at 11.08% in Q1 2026, up 1394.0% YoY from 0.74% in Q1 2025, and up 9.29% on a QoQ basis from 10.14% in Q4 2025.
Bioventus (BVS) Return on Capital Employed (2021 - 2026) Analysis & Trends
Bioventus (BVS) has 6 years of Return on Capital Employed data on file, last reported at 11.08% in Q1 2026.
- Quarterly Return on Capital Employed rose 1394.0% year-over-year to 11.08% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 11.08% (up 1394.0% YoY) and the FY2025 annual result came in at 9.9%, up 1261.0% from the prior year.
- Return on Capital Employed improved to 11.08% in Q1 2026, from 10.14% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 11.08% in Q1 2026 to a low of 33.35% in Q3 2023.
- A 5-year average of 5.8% and a median of 3.02% in 2022 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2023 — Return on Capital Employed plunged 3046 bps — and 2024, when it soared 2926 bps.
- Tracing BVS's Return on Capital Employed over 5 years: stood at 15.47% in 2022, then advanced by 17 bps to 12.86% in 2023, then jumped by 78 bps to 2.82% in 2024, then soared by 459 bps to 10.14% in 2025, then rose by 9 bps to 11.08% in 2026.
- The last three Return on Capital Employed figures came in at 11.08% (Q1 2026), 10.14% (Q4 2025), and 7.78% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 7.98% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 13.69% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 10.83% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 11.99% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 27.21% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 9.47% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 12.84% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 12.08% |
| 10 | Bioventus | 972.56 Mn | 943.11 Mn | 105.67 Mn | 11.44% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 11.44% |
| Mar 28, 2026 | 11.08% |
| Dec 31, 2025 | 10.14% |
| Sep 27, 2025 | 7.78% |
| Jun 28, 2025 | 6.74% |
| Mar 29, 2025 | -2.85% |
| Dec 31, 2024 | -2.82% |
| Sep 28, 2024 | -3.82% |
| Jun 29, 2024 | -4.09% |
| Mar 30, 2024 | 2.43% |
| Dec 31, 2023 | -12.86% |
| Sep 30, 2023 | -14.86% |
| Jul 1, 2023 | -33.35% |
| Apr 1, 2023 | -25.47% |
| Dec 31, 2022 | -15.47% |
| Oct 1, 2022 | -15.25% |
| Jul 2, 2022 | -2.88% |
| Apr 2, 2022 | -3.02% |
| Dec 31, 2021 | 1.59% |
| Oct 2, 2021 | 4.31% |